- Home
- CTXR vs JFU Comparison
CTXR vs JFU Comparison
Compare CTXR & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- JFU
- Stock Information
- Founded
- CTXR 2007
- JFU 2006
- Country
- CTXR United States
- JFU China
- Employees
- CTXR N/A
- JFU N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- CTXR Health Care
- JFU Finance
- Exchange
- CTXR Nasdaq
- JFU Nasdaq
- Market Cap
- CTXR 20.8M
- JFU 17.1M
- IPO Year
- CTXR N/A
- JFU 2019
- Fundamental
- Price
- CTXR $1.13
- JFU $2.74
- Analyst Decision
- CTXR Strong Buy
- JFU
- Analyst Count
- CTXR 3
- JFU 0
- Target Price
- CTXR $53.00
- JFU N/A
- AVG Volume (30 Days)
- CTXR 473.1K
- JFU 22.1K
- Earning Date
- CTXR 08-12-2025
- JFU 01-01-0001
- Dividend Yield
- CTXR N/A
- JFU N/A
- EPS Growth
- CTXR N/A
- JFU N/A
- EPS
- CTXR N/A
- JFU 0.58
- Revenue
- CTXR N/A
- JFU $42,467,427.00
- Revenue This Year
- CTXR N/A
- JFU N/A
- Revenue Next Year
- CTXR $851.67
- JFU N/A
- P/E Ratio
- CTXR N/A
- JFU $4.47
- Revenue Growth
- CTXR N/A
- JFU N/A
- 52 Week Low
- CTXR $0.65
- JFU $1.01
- 52 Week High
- CTXR $15.25
- JFU $3.60
- Technical
- Relative Strength Index (RSI)
- CTXR 39.44
- JFU 73.52
- Support Level
- CTXR $1.10
- JFU $2.53
- Resistance Level
- CTXR $1.25
- JFU $2.75
- Average True Range (ATR)
- CTXR 0.09
- JFU 0.20
- MACD
- CTXR -0.01
- JFU 0.01
- Stochastic Oscillator
- CTXR 8.49
- JFU 88.70
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.